Clinical trial
A Controlled Trial to Investigate the Efficacy and Safety of Frovatriptan to…
NCT00475514 · Endo Pharmaceuticals, Industry · Completed
Key facts
| NCT number | NCT00475514 |
|---|---|
| Title | A Controlled Trial to Investigate the Efficacy and Safety of Frovatriptan to Prevent Menstrual Migraine |
| Official title | A Double-blind, Placebo-controlled, Parallel Group Study to Assess the Efficacy, and Safety of Oral Frovatriptan in the Prevention on Menstrually-related Migraine (MRM) Headaches in a 'Difficult to Treat' Population |
| Lead sponsor | Endo Pharmaceuticals, Industry |
| Status | Completed |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Migraine |
| Intervention type | Drug |
| Interventions | Frovatriptan 2.5mg QD, Frovatriptan 2.5 mg BID, placebo |
| Enrollment | 500 |
| Start date | Oct 1, 2004 |
| Primary completion | Mar 1, 2006 |
| Completion | Mar 1, 2006 |
| First posted | May 21, 2007 |
| Last update posted | Jan 2, 2024 |
At a glance
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: